The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy

BACKGROUND/AIMS: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir (ADV) was the most potent regimen for chronic hepatitis B (CHB) patients who fail to respond to rescue therapy for drug resistance. We analyzed the efficacy of ETV-ADV combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong Han, Ahn, Sung Hyun, Ko, Soon Young, Choe, Won Hyeok, Kim, Kyun-Hwan, Kwon, So Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946405/
https://www.ncbi.nlm.nih.gov/pubmed/27304549
http://dx.doi.org/10.3350/cmh.2015.0053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946405/
https://www.ncbi.nlm.nih.gov/pubmed/27304549
http://dx.doi.org/10.3350/cmh.2015.0053

Ejemplares similares